The DOI matches its OpenAlex record; 37 of the 37 references it cites were found in a registry or an index.
Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis
Open accessAbstract
To determine the complications, toxicities, and compliance of long term testosterone replacement in hypogonadal males, we retrospectively assessed 45 elderly hypogonadal men receiving testosterone replacement therapy and 27 hypogonadal men taking testosterone. Hypogonadism was defined as a bioavailable testosterone serum concentration of 72 ng/dL or less. Both groups received baseline physical examinations and blood tests. The testosterone-treated group received 200 mg testosterone enanthate or cypionate im every 2 weeks, and follow-up examinations and blood samplings were performed every 3 months. The control group had a single follow-up blood test and physical examination. There was no significant difference in the initial blood tests in the two groups. At 2 yr follow-up, only the hematocrit showed a statistically significant increase in the testosterone-treated group compared to the control group (P < 0.001). A decrease in the urea nitrogen to creatinine ratio and an increase in the prostate-specific antigen concentration was not statistically significant. Eleven (24%) of the testosterone-treated subjects developed polycythemia sufficient to require phlebotomy or the temporary withholding of testosterone, one third of which occurred less than 1 yr after starting testosterone treatment. There was no significant difference in the incidence of new illness in the two groups during the 2-yr follow-up. Although self-assessment of libido was dramatically improved in the testosterone-treated group (P < 0.0001), approximately one third of the subjects discontinued therapy. In conclusion, testosterone replacement therapy appears to be well tolerated by over 84% of the subjects. Long term testosterone replacement to date appears to be a safe and effective means of treating hypogonadal elderly males, provided that frequent follow-up blood tests and examinations are performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & The Measurement Committee of the American Urological Association (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36966-5 · Cited by 3,436
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O'leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & Measurement Committee of the American Urological Association (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.071 · Cited by 1,940
Biological Actions of Androgens
MOORADIAN, A. D., MORLEY, J. E., & KORENMAN, S. G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-1 · Cited by 1,080
Self-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Effects of testosterone supplementation in the aging male
Tenover, J. L. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 810
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men
NEAVES, W. B., JOHNSON, L., PORTER, J. C., PARKER, C. R., & PETTY, C. S. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-4-756 · Cited by 495 · cited 1×
“However, the age-related decline in testicular Leydig cells (16) make primary hypogonadism a relatively common occurrence in the very old, and it is likely that both primary and secondary hypogonadism, to varying degrees, are responsible for the decline in testosterone levels seen with advancing age.”
BackgroundEffects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 463
Self-citationVERMEULEN, A. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-221 · Cited by 388
Hormonal Changes and Sexual Function in Aging Men*
DAVIDSON, J. M., CHEN, J. J., CRAPO, L., GRAY, G. D., GREENLEAF, W. J., & CATANIA, J. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-71 · Cited by 377
Testosterone Therapy in Glucocorticoid-Treated Men
Reid, I. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100065008 · Cited by 365
Leydig Cell Function in Normal Men: Effect of Age, Life-Style, Residence, Diet, and Activity*
DESLYPERE, J. P., & VERMEULENf, A. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-5-955 · Cited by 343
Behre, H. M., Bohmeyer, J., & Nieschlag, E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03929.x · Cited by 335
Secondary Hypogonadism in Older Men: Its Relation to Impotence*
KORENMAN, S. G., MORLEY, J. E., MOORADIAN, A. D., DAVIS, S. S., KAISER, F. E., SILVER, A. J., VIOSCA, S. P., & GARZA, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-963 · Cited by 320
Self-citationImpotence in Medical Clinic Outpatients
Slag, M. F. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330370046029 · Cited by 315
CHANGES IN THE PITUITARY‐TESTICULAR SYSTEM WITH AGE
BAKER, H. W. G., BURGER, H. G., de KRETSER, D. M., HUDSON, B., O'CONNOR, S., WANG, C., MIROVICS, A., COURT, J., DUNLOP, M., & RENNIE, G. C. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb01964.x · Cited by 306
Jw, F., Samuels, A. I., & La, M. (1971) · PubMed · Cited by 285
Declining testicular function with age
Stearns, E. L., MacDonnell, J. A., Kaufman, B. J., Padua, R., Lucman, T. S., Winter, J. S. D., & Faiman, C. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90850-x · Cited by 266
The use and misuse of androgens
Wilson, J. D., & Griffin, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90159-6 · Cited by 257
TENOVER, J. S., MATSUMOTO, A. M., PLYMATE, S. R., & BREMNER, W. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1118 · Cited by 256
MATSUMOTO, A. M., SANDBLOM, R. E., SCHOENE, R. B., LEE, K. A., GIBLIN, E. C., PIERSON, D. J., & BREMNER, W. J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00161.x · Cited by 247
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men
Bagatell, C. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.561 · Cited by 244
Decreased Bioavailable Testosterone in Aging Normal and Impotent Men*
NANKIN, H. R., & CALKINS, J. H. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1418 · Cited by 236
Impotence and Aging: Clinical and Hormonal Factors
Kaiser, F. E., Viosca, S. P., Morley, J. E., Mooradian, A. D., Davis, S. S., & Korenman, S. G. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb04021.x · Cited by 220
Self-citationHigh-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered
Friedl, K. E., Hannan, C. J., Jones, R. E., & Plymate, S. R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90150-b · Cited by 154
Winters, S. J., & Troen, P. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-3-560 · Cited by 136
Hormonal Therapy of Male Hypogonadism
Matsumoto, A. M. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30072-0 · Cited by 115
Drinka, P. J., Jochen, A., Cuisinier, M. C., Bloom, R. J., Rudman, I. W., & Rudman, D. R. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb05534.x · Cited by 105
Schulte-Beerbühl, M., & Nieschlag, E. (1980) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44543-7 · Cited by 97
Warner, B. A., Dufau, M. L., & Santen, R. J. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-263 · Cited by 90
Zmuda, J. M., Fahrenbach, M. C., Younkin, B., Bausserman, L., Terry, R. B., Catlin, D. H., & Thompson, P. D. (1993) · Metabolism · doi:10.1016/0026-0495(93)90101-s · Cited by 74
Krauss, D. J., Taub, H. A., Lantinga, L. J., Dunsky, M. H., & Kelly, C. M. (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)38168-5 · Cited by 71
Hormone kinetics after intramuscular testosterone cypionate
Nankin, H. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59237-1 · Cited by 57
Krabbe, S., CHRISTENSEN, T., WORM, J., Christiansen, C., & Transbøl, I. (1978) · Acta Paediatrica · doi:10.1111/j.1651-2227.1978.tb17818.x · Cited by 40
Dose-dependent effects of testosterone on feeding and body weight in male rats
Núñez, A. A. (1982) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(82)91888-x · Cited by 20
Morley, J. E., & Solomon, D. H. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb03460.x · Cited by 10
Self-citation
Cited by
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Risks of testosterone-replacement therapy and recommendations for monitoring.
Rhoden, E. L., & Morgentaler, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022251 · Cited by 705
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
Self-citationEnglish, K. M., Steeds, R. P., Jones, T. H., Diver, M. J., & Channer, K. S. (2000) · Circulation · doi:10.1161/01.cir.102.16.1906 · Cited by 582
Effects of testosterone on sexual function in men: results of a meta‐analysis
Isidori, A. M., Giannetta, E., Gianfrilli, D., Greco, E. A., Bonifacio, V., Aversa, A., Isidori, A., Fabbri, A., & Lenzi, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02350.x · Cited by 492
Metadata
- Authors
- Hajjar, R. R., Kaiser, F. E., & Morley, J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- Oxford University Press
- Published
- 1997-11-01
- Volume
- 82
- Issue
- 11
- Pages
- 3793-3796
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2138364455
- Cited by
- 325
- References
- 37
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.